Detalles de la búsqueda
1.
Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
Diabetes Obes Metab
; 22(7): 1056-1061, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037699
2.
First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes.
Diabetes Obes Metab
; 21(7): 1689-1694, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30938036
3.
Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.
JAMA
; 312(9): 915-22, 2014 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25182100
4.
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
Diabetes Technol Ther
; 24(2): 84-92, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34515521
5.
Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study.
Diabetes Technol Ther
; 22(1): 48-52, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31418587
6.
Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
Diabetes Technol Ther
; 22(5): 422-427, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31697182
7.
Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device.
Surg Obes Relat Dis
; 5(2): 224-9; discussion 229-30, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18996767
8.
Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor.
Diabetes Technol Ther
; 21(12): 677-681, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385732
9.
A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study.
Diabetes Technol Ther
; 21(5): 231-237, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30925083
10.
Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial.
Obes Surg
; 27(1): 169-176, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27506803
11.
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study.
Obes Surg
; 26(5): 983-9, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27048437
12.
Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study.
Obes Surg
; 26(5): 1021-8, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26471783
13.
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial.
J Obes
; 2015: 365604, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26246907
14.
Description and evaluation of a ventriculo-coronary artery bypass device that provides bi-directional coronary flow.
Eur J Cardiothorac Surg
; 25(1): 43-50, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14690731
15.
Effects of high-frequency alternating current on axonal conduction through the vagus nerve.
J Neural Eng
; 8(5): 056013, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21918293
16.
Erratum to: Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study.
Obes Surg
; 26(5): 1029, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26525980
Resultados
1 -
16
de 16
1
Próxima >
>>